Medtech InsightFour Deaths Linked To Recall Of Abiomed Impella Heart Pumps The FDA has designated a recall of various Impella Left-Sided Blood Pumps from Abiomed, Inc. as class I, its most serious. The agency sa
In Vivo“I would never have thought 2021 would turn out as it did,” said John Babitt, a Minneapolis-based partner with EY. He was referring to the uncharted heights achieved last year in medtech M&A deal-maki
Medtech InsightTeleflex is selling some of its respiratory device assets to focus more resources on its core vascular, anesthesia, surgical and interventional urology businesses. On 18 May, Teleflex announced a def
Medtech InsightThe latest Medtech Insight sales ranking of the top 100 publicly-traded medtech manufacturers is COVID-19-affected for a relatively sizeable proportion of companies ̶ those whose reporting perio